|
Name |
Cytochalasin J2
|
Molecular Formula | C28H35NO3 | |
IUPAC Name* |
(1R,2R,3E,5Z,7S,9E,11R,12S,14S,15R,16S)-16-benzyl-2,12-dihydroxy-5,7,14-trimethyl-13-methylidene-17-azatricyclo[9.7.0.01,15]octadeca-3,5,9-trien-18-one
|
|
SMILES |
C[C@H]/1C/C=C/[C@H]2[C@@H](C(=C)[C@H]([C@@H]3[C@@]2([C@@H](/C=C/C(=C1)/C)O)C(=O)N[C@H]3CC4=CC=CC=C4)C)O
|
|
InChI |
InChI=1S/C28H35NO3/c1-17-9-8-12-22-26(31)20(4)19(3)25-23(16-21-10-6-5-7-11-21)29-27(32)28(22,25)24(30)14-13-18(2)15-17/h5-8,10-15,17,19,22-26,30-31H,4,9,16H2,1-3H3,(H,29,32)/b12-8+,14-13+,18-15-/t17-,19+,22-,23-,24+,25-,26+,28+/m0/s1
|
|
InChIKey |
CZABEFNJKKLRKT-ZCTQIHNESA-N
|
|
Synonyms |
Cytochalasin J2
|
|
CAS | NA | |
PubChem CID | 139591401 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 433.6 | ALogp: | 3.6 |
HBD: | 3 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 69.6 | Aromatic Rings: | 4 |
Heavy Atoms: | 32 | QED Weighted: | 0.597 |
Caco-2 Permeability: | -4.898 | MDCK Permeability: | 0.00001790 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.979 |
Human Intestinal Absorption (HIA): | 0.043 | 20% Bioavailability (F20%): | 0.137 |
30% Bioavailability (F30%): | 0.009 |
Blood-Brain-Barrier Penetration (BBB): | 0.498 | Plasma Protein Binding (PPB): | 89.36% |
Volume Distribution (VD): | 0.72 | Fu: | 5.83% |
CYP1A2-inhibitor: | 0.335 | CYP1A2-substrate: | 0.12 |
CYP2C19-inhibitor: | 0.642 | CYP2C19-substrate: | 0.64 |
CYP2C9-inhibitor: | 0.699 | CYP2C9-substrate: | 0.154 |
CYP2D6-inhibitor: | 0.314 | CYP2D6-substrate: | 0.604 |
CYP3A4-inhibitor: | 0.929 | CYP3A4-substrate: | 0.277 |
Clearance (CL): | 7.442 | Half-life (T1/2): | 0.21 |
hERG Blockers: | 0.085 | Human Hepatotoxicity (H-HT): | 0.914 |
Drug-inuced Liver Injury (DILI): | 0.396 | AMES Toxicity: | 0.161 |
Rat Oral Acute Toxicity: | 0.872 | Maximum Recommended Daily Dose: | 0.979 |
Skin Sensitization: | 0.237 | Carcinogencity: | 0.039 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.013 |
Respiratory Toxicity: | 0.971 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004341 | 0.806 | D0I0DL | 0.244 | ||||
ENC006059 | 0.806 | D01TSI | 0.240 | ||||
ENC006133 | 0.762 | D06CWH | 0.237 | ||||
ENC005129 | 0.745 | D0SP3D | 0.233 | ||||
ENC004243 | 0.731 | D09NNH | 0.233 | ||||
ENC004369 | 0.731 | D0V3ZA | 0.233 | ||||
ENC004120 | 0.724 | D0H6TP | 0.231 | ||||
ENC004370 | 0.714 | D0IN7I | 0.231 | ||||
ENC004918 | 0.710 | D0E4DW | 0.231 | ||||
ENC004544 | 0.710 | D0D7KC | 0.231 |